EWTX Stock: Edgewise Therapeutics, Inc. Stock Price, Analysis & Insights
Get live ewtx stock price $27.29, comprehensive Edgewise Therapeutics, Inc. stock analysis, charts, news, and expert forecast. Real-time ewtx stock data and investment insights.
Loading chart...
Company Overview
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.
Company Information
- CEO
- Kevin Koch
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 117
Contact Information
- Website
- https://www.edgewisetx.com
- Address
- 3415 Colorado Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.27) may provide portfolio stability
Business Model & Strategy
Edgewise Therapeutics, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Kevin Koch, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Edgewise Therapeutics, Inc. competes in the Biotechnology within the broader Healthcare. With 2.9 billion in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Edgewise Therapeutics, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Edgewise Therapeutics, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Edgewise Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Edgewise Therapeutics, Inc.
- ⚠Investors should consider how Edgewise Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
2.89B
P/E Ratio
-17.38
Beta
0.27
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 2.89B market capitalization
- Trading Volume: 3.59M shares traded today
- Price Range: 52-week range of $10.60 - $30.48
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. (EWTX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 2.89B, the company represents a significant player in its market. The stock is currently trading at $27.29 with a positivedaily change of 25.50%.
The company's 117 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -17.38, beta of 0.27, and 52-week price range from $10.60 to $30.48when evaluating investment opportunities.
Why Invest in Edgewise Therapeutics, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Kevin Koch
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.